Effects of Anesthesia and Recovery from Ketamine Racemate and Enantiomers on Regional Cerebral Glucose Metabolism in Rats

Anesthesiology

Volumn 100, Issue 5, 2004, Pages 1172-1178

  Freo, Ulderico ^a   Ori, Carlo ^b  

^a Ospedale Civile   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CARBON 14; DEOXYGLUCOSE; GLUCOSE; KETAMINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;

ANESTHESIOLOGICAL TECHNIQUES; ANESTHETIC RECOVERY; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUDITORY RESPONSE; AUTORADIOGRAPHY; BASAL GANGLION; BRAIN CORTEX; BRAIN METABOLISM; BRAIN REGION; BRAIN STEM; CEREBELLUM; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACTIVITY; DRUG FORMULATION; ENANTIOMER; GENERAL ANESTHESIA; GLUCOSE METABOLISM; LIMBIC CORTEX; MALE; NONHUMAN; PRIORITY JOURNAL; RACEMIC MIXTURE; RAT; THALAMUS;

ANESTHESIA; ANESTHESIA RECOVERY PERIOD; ANIMALS; BRAIN; GLUCOSE; KETAMINE; MALE; RATS; RATS, INBRED F344; STEREOISOMERISM;

EID: 2142756592     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000542-200405000-00020     Document Type: Article

References (48)

1. Reich DL, Silvay G: Ketamine: An update on the first twenty-five years of clinical experience. Can J Anaesth 1989; 36:186-97
2. Corssen G, Domino EF: Dissociative anesthesia: Further pharmacological studies and first clinical experience with phencyclidine derivative C1-581. Anesth Analg 1966; 45:29-40
3. Crosby G, Crane AM, Sokoloff L: A comparison of local rates of glucose utilization in spinal cord and brain in conscious and nitrous oxide- or pentobarbital-treated rats. ANESTHESIOLOGY 1984; 61:434-8
4. Ori C, Dam M, Pizzolato G, Battistin L, Giron G: Effects of isoflurane anesthesia on local cerebral glucose utilization in the rat. ANESTHESIOLOGY 1986; 65:152-6
5. Dam M, Ori C, Pizzolato G, Ricchieri GL, Pellegrini A, Giron GP, Battistin L: The effects of propofol anesthesia on local cerebral glucose utilization in the rat. ANESTHESIOLOGY 1990; 73:499-505
6. Freo U, Ori C: Mapping cerebral metabolic and blood effects of general anesthetics, Anaesthesia, Pain, Intensive Care and Emergency Medicine, Vol 17. Edited by Gullo A. Milan, Spinger-Verlag, 2003, pp 877-90
7. Cavazzuti M, Porro CA, Biral GP, Benassi C, Barbieri GC: Ketamine effects on local cerebral blood flow and metabolism in the rat. J Cereb Blood Flow Metab 1987; 7:806-11
8. Crosby G, Crane AM, Sokoloff L: Local changes in cerebral glucose utilization during ketamine anesthesia. ANESTHESIOLOGY 1982; 56:437-43
9. Davis DW, Mans AM, Biebuyck JF, Hawkins RA: The influence of ketamine on regional brain glucose use. ANESTHESIOLOGY 1988, 69:199-205
10. Oguchi K, Arakawa K, Nelson SR, Samson F: The influence of droperidol, diazepam, and physostigmine on ketamine-induced behavior and brain regional glucose utilization in rat. ANESTHESIOLOGY 1982; 57:353-8
11. Winters WD, Ferrar-Allado T, Guzman-Flores C, Alcaraz M: The cataleptic state induced by ketamine: A review of the neuropharmacology of anesthesia. Neuropharmacology 1972; 11:303-15
12. Benthuysen JL, Hance AJ, Quam DD, Winters WD: Comparison of isomers of ketamine on catalepsy in the rat and electrical activity of the brain and behaviour in the cat. Neuropharmacology 1989; 28:1003-9
13. Ryder S, Way WL, Trevor AJ: Comparative pharmacology of the optical isomers of ketamine in mice. Eur J Pharmacol 1978; 49:15-23
14. Oye I, Husteveit O, Maurset A, Ratti Moberg E, Paulsen O, Skoglund LA: The chiral forms of ketamine as probes for NMDA-receptor function in humans, NMDA Receptors Related Agents: Biochemistry, Pharmacology and Behaviour. Edited by Kameyama T, Nabeshima T, Domino EF. Ann Arbor, NPP Books, 1992, pp 381-9
15. Hirota K, Okawa H, Appadu BL, Grandy DK, Devi LA, Lambert DG: Stereoselective interaction of ketamine with recombinant mu, kappa, and delta opioid receptors expressed in Chinese hamster ovary cells. ANESTHESIOLOGY 1999; 90:174-82
16. Anis NA, Berry SC, Burton NR, Lodge D: The dissociative anaesthetics, ketamine and phencyclidine, selectively reduce excitation of central mammalian neurones by N-methyl-aspartate. Br J Pharmacol 1983; 79:565-75
17. Hancock PJ, Stamford JA: Stereospecific effects of ketamine on dopamine efflux and uptake in the rat nucleus accumbens. Br J Anaesth 1999; 82:603-8
18. Joo G, Horvath G, Klimscha W, Kekesi G, Dobos I, Szikszay M, Benedek G: The effects of ketamine and its enantiomers on the morphine- or dexmedetomidine-induced antinociception after intrathecal administration in rats. ANESTHESIOLOGY 2000; 93:231-41
19. Durieux ME, Nietgen GW: Synergistic inhibition of muscarinic signaling by ketamine stereoisomers and the preservative benzethonium chloride. ANESTHESIOLOGY 1997; 86:1326-33
20. Sasaki T, Andoh T, Watanabe I, Kamiya Y, Itoh H, Higashi T, Matsuura T: Nonstereoselective inhibition of neuronal nicotinic acetylcholine receptors by ketamine isomers. Anesth Analg 2000; 91:741-8
21. Brady KT, Balster RL: Discriminative stimulus properties of ketamine stereoisomers in phencyclidine-trained rats. Pharmacol Biochem Behav 1982; 17:291-305
22. Puu G, Koch M, Artursson E: Ketamine enantiomers and acetylcholinesterase. Biochem Pharmacol 1991; 41:2043-5
23. Sokoloff L: The radioactive deoxyglucose method: Theory, procedure and applications for the measurements of local glucose utilization in the central nervous system. Adv Neurochem 1982; 4:1-82
24. 14C]deoxyglucose method for measurement of local cerebral glucose utilization: Theory, procedure and normal value in the conscious and anesthetized albino rat. J Neurochem 1985; 28:897-916
25. Freo U: Cerebral metabolic effects of serotonin drugs and neurotoxins. Life Sci 1996; 59:877-91
26. Freo U, Pizzolato G, Dam M, Ori C, Battistin L: A short review of cognitive and functional neuroimaging studies of cholinergic drugs: Implications for therapeutic potentials. J Neural Transm 2002; 109:857-70
27. Orzi F, Morelli M, Fieschi C, Pontieri FE: Metabolic mapping of the pharmacological and toxicological effects of dopaminergic drugs in experimental animals. Cerebrovasc Brain Metab Rev 1993; 5:95-121
28. National Institutes of Health: Guide for the Care and Use of Laboratory Animals. Bethesda, National Institutes of Health, revised 1978. Publication No. 80-23
29. Marietta MP, Way WL, Castagnoli N Jr, Trevor AJ: On the pharmacology of the ketamine enantiomorphs in the rat. J Pharmacol Exp Ther 1977; 202:157-65
30. Paxinos G, Watson C: The Rat Brain in Stereotaxic Coordinates. New York, Academic, 1982
31. Geisslinger G, Hering W, Thomann P, Knoll R, Kamp HD, Brune K: Pharmacokinetics and pharmacodynamics of ketamine enantiomers in surgical patients using a stereoselective analytical method. Br J Anaesth 1993; 70:666-71
32. Schuttler J, Stanski DR, White PF, Trevor AJ, Horal Y, Verotta D, Sheiner LB: Pharmacodynamic modeling of the EEG effects of ketamine and its enantiomers in man. J Pharmacokinet Biopharm 1987; 15:241-53
33. Engelhardt W, Stahl K, Marouche A, Hartung E, Dierks T: Ketamine racemate versus S-(+)-ketamine with or without antagonism with physostigmine: A quantitative EEG study on volunteers. Anaesthesist 1994; 43(suppl 2):S76-82
34. Sharkey J, Ritchie IM, Butcher SP, Kelly JS: Differential effects of competitive (CGS19755) and non-competitive (MK 801) NMDA receptor antagonists upon local cerebral blood flow and local cerebral glucose utilisation in the rat. Brain Res 1994; 651:27-36
35. Moghaddam B, Adams B, Verma A, Daly D: Activation of glutamatergic neurotransmission by ketamine: A novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex. J Neurosci 1997; 17:2921-7
36. Persson J, Hasselstrom J, Maurset A, Oye I, Svensson JO, Almqvist O, Scheinin H, Gustafsson LL, Almqvist O: Pharmacokinetics and non-analgesic effects of S- and R-ketamines in healthy volunteers with normal and reduced metabolic capacity. Eur J Clin Pharmacol 2002; 57:869-75
37. Kubota T, Anzawa N, Hirota K, Yoshida H, Kushikata T, Matsuki A: Effects of ketamine and pentobarbital on noradrenaline release from the medial prefrontal cortex in rats. Can J Anaesth 1999; 46:388-92
38. Lindefors N, Barati S, O'Connor WT: Differential effects of single and repeated ketamine administration on dopamine, serotonin and GABA transmission in rat medial prefrontal cortex. Brain Res 1997; 759:205-12
39. Taguchi K, Andresen MJ, Hentall ID: Acetylcholine release from the midbrain interpeduncular nucleus during anesthesia. Neuroreport 1991; 2:789-92
40. Irifune M, Fukuda T, Nomoto M, Sato T, Kamata Y, Nishikawa T, Mietani W, Yokoyama K, Sugiyama K, Kawahara M: Effects of ketamine on dopamine metabolism during anesthesia in discrete brain regions in mice: Comparison with the effects during the recovery and subanesthetic phases. Brain Res 1997; 763:281-4
41. Kolada I, Kmieciak-Kolada K, Huzarska M, Dyaczynska-Herman A, Herman ZS: Influence of ketamine and its interactions with morphine and nalbuphine on the level of enkephalins in some parts of the brain and spinal cord. Pol J Pharmacol 1994; 46:139-46
42. Kelland MD, Soltis RP, Boldry RC, Walters JR: Behavioral and electrophysiological comparison of ketamine with dizocilpine in the rat. Physiol Behav 1993; 54:547-54
43. Church J, Lodge D, Berry SC: Differential effects of dextrorphan and levorphanol on the excitation of rat spinal neurons by amino acids. Eur J Pharmacol 1985; 111:185-90
44. Kessler JP, Cherkaoui N, Catalin D, Jean A: Swallowing responses induced by microinjection of glutamate and glutamate agonists into the nucleus tractus solitarius of ketamine-anesthetized rats. Exp Brain Res 1990; 83:151-8
45. Daniell LC: The noncompetitive N-methyl-D-aspartate antagonists, MK-801, phencyclidine and ketamine, increase the potency of general anesthetics. Pharmacol Biochem Behav 1990; 36:111-5
46. 3H]MK-801 binding and reversal by glycine. Neurosci Lett 1991; 132:73-6
47. Puil E, el-Beheiry H, Baimbridge KG: Anesthetic effects on glutamate-stimulated increase in intraneuronal calcium. J Pharmacol Exp Ther 1990; 255:955-61
48. Gonzales JM, Loeb AL, Reichard PS, Irvine S: Ketamine inhibits glutamate-, N-methyl-D-aspartate-, and quisqualate-stimulated cGMP production in cultured cerebral neurons. ANESTHESIOLOGY 1995; 82:205-13